Results 21 to 30 of about 40,797 (259)

Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center

Saudi Pharmaceutical Journal, 2021
Introduction: Appropriate prescribing of thromboprophylaxis according to guidelines’ recommendations can heighten over- or underutilization risk. The study intended to evaluate the safety and effectiveness of appropriate/inappropriate thromboprophylaxis ...
Ghazwa B. Korayem, Omar A. Alshaya, Norah S. Alsubaie, Dalal A. Alabdulkarim, Omar A. Almohammed, Osamah M. Alfayez, Majed S. Al Yami   +6 more
doaj   +1 more source

Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?

Thrombosis and Haemostasis, 2020
Acutely ill medical patients are at heightened risk for venous thromboembolism, a term that combines deep vein thrombosis (DVT) and its more severe complication, pulmonary embolism. 1,2 Although the incidence of venous thromboembolism in medical patients
M. Cattaneo, Elena Bertinato, S. Birocchi, Carolina Brizio, Daniele Malavolta, Marco Manzoni, G. Muscarella, M. Orlandi   +7 more
semanticscholar   +1 more source

Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis

Therapeutic Advances in Medical Oncology, 2020
Background: Thrombosis is a common complication in patients with cancer. Whether thromboprophylaxis could benefit patients with cancer is unclear.
Miao Liu, Guiyue Wang, Yuhang Li, Hongliang Wang, Haitao Liu, Nana Guo, Ci Han, Yahui Peng, Mengyuan Yang, Yansong Liu, Xiaohui Ma, Kaijiang Yu, Changsong Wang   +12 more
doaj   +1 more source

Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis

Thrombosis Update, 2022
Introduction: The incidence of thromboembolism during COVID-19 and the use of thromboprophylaxis vary greatly between studies. Only a few studies have investigated the rate of thromboembolism post-discharge.
Birgitte Tholin, Hilde Fiskvik, Anders Tveita, Galina Tsykonova, Helene Opperud, Kari Busterud, Clarisse Mpinganzima, Lamya Garabet, Jamal Ahmed, Knut Stavem, Waleed Ghanima   +10 more
doaj   +1 more source

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors

Journal of Thrombosis and Thrombolysis, 2020
Coagulopathy in COVID-19 is a burning issue and strategies to prevent thromboembolic events are debated and highly heterogeneous. The objective was to determine incidence and risk factors of venous thromboembolism (VTE) in COVID-19 inpatients receiving ...
M. Artifoni, G. Danic, G. Gautier, Pascal Gicquel, D. Boutoille, F. Raffi, A. Néel, R. Lecomte   +7 more
semanticscholar   +1 more source

Contemporary adequacy of thromboprophylaxis in acutely ill medical patients in Switzerland: a bi-centric prospective cohort

Swiss Medical Weekly, 2023
BACKGROUND: Venous thromboembolism is a dreaded complication of hospitalised patients, with associated morbidity, mortality and increased healthcare costs.
Marco Marando, Katherine Blondon, Pauline Darbellay Farhoumand, Mathieu Nendaz, Damien Grauser, Alain Sallet, Adriana Tamburello, Marco Pons, Marc Righini , Pietro Gianella, Marc Blondon   +10 more
doaj   +1 more source

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. [PDF]

, 2018
It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein
Burra, P, Campello, E, Russo, Fp., Simioni, P, Spiezia, L, Zanetto, A   +5 more
core   +1 more source

Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review [PDF]

, 2016
Objective:Atrial Fibrillation (AF) is associated with dementia. If AF-related cognitive decline is driven by cerebral embolic events, thromboprophylaxis may impact on this.
Lane, Deirdre A., Moffitt, Peter, O'Connell, Janice, Park, Helen, Quinn, Terence J.   +4 more
core   +2 more sources

Prescribing patterns of thromboprophylaxis post-bariatric surgeries: no additional benefits of extended prophylaxis

Future Journal of Pharmaceutical Sciences, 2023
Background Venous thromboembolism is one of the critical complications of bariatric surgeries resulting in life-threatening outcomes. The benefits and duration of appropriate thromboprophylaxis in the morbidly obese patients stay unclear.
Abdullah S. Almalki, Heba Adel Al Recheq, Eshtyage Bajnaid, Sherif Boraii, Doaa H. Abdelaziz, Seif El Hadidi   +5 more
doaj   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M, Athanasoulis CA, Bergqvist D, Bergqvist D, Buller HR, Clagett PG, Da Silva MS, Decousus H, ENOXACAN Study Group, Falanga A, Geerts WH, Gitter MJ, Goldenberg N, Gomes MPV, Green D, Haas S, Heit JA, Hettiarachchi RJK, Hull R, Hutten BA, International Multicentre Trial, Johnson MJ, Kakkar VV, Karthaus M, Koopman MMW, Levine MN, Mousa S A, Mousa SA, Prandoni P, Rasmussen MS, Rickles FR, Sallah S, Samama M, Siragusa B, The Columbus Investigators, White RH, Zacharski LR   +36 more
core   +1 more source